Literature DB >> 8851601

Identification of a class of sulfonamides highly active against dihydropteroate synthase form Toxoplasma gondii, Pneumocystis carinii, and Mycobacterium avium.

L C Chio1, L A Bolyard, M Nasr, S F Queener.   

Abstract

Sulfanilanilides with 3',5'-halogen substitutions had Ki values 6- to 57-fold lower than the Ki of sulfamethoxazole when tested against dihydropteroate synthase from Toxoplasma gondii. The compounds acted as competitive inhibitors. These compounds were also active against dihydropteroate synthase from Pneumocystis carinii, Mycobacterium avium, and Escherichia coli but were not significantly more active than sulfamethoxazole. The compounds were significantly more active in culture than were standard agents. Against T. gondii in culture, 50% inhibitory concentrations were 7- to 30-fold lower than that of sulfadiazine; against P. carinii in culture, a concentration of 100 microM caused 33 to 95% inhibition of growth, compared with 9% inhibition with 100 microM sulfamethoxazole.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851601      PMCID: PMC163188     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Tricyclic 2,4-diaminopyrimidines with broad antifolate activity and the ability to inhibit Pneumocystis carinii growth in cultured human lung fibroblasts in the presence of leucovorin.

Authors:  A Rosowsky; J H Freisheim; J B Hynes; S F Queener; M Bartlett; J W Smith; H Lazarus; E J Modest
Journal:  Biochem Pharmacol       Date:  1989-08-15       Impact factor: 5.858

2.  Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.

Authors:  S Merali; Y Zhang; D Sloan; S Meshnick
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  In vitro activities of acridone alkaloids against Pneumocystis carinii.

Authors:  S F Queener; H Fujioka; Y Nishiyama; H Furukawa; M S Bartlett; J W Smith
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

4.  Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo.

Authors:  S F Queener; M S Bartlett; J D Richardson; M M Durkin; M A Jay; J W Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

5.  Phosphanilic acid inhibits dihydropteroate synthase.

Authors:  R G Eagon; A T McManus
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

6.  Susceptibility of Pneumocystis carinii to artemisinin in vitro.

Authors:  S Merali; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

7.  Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.

Authors:  C J Allegra; D Boarman; J A Kovacs; P Morrison; J Beaver; B A Chabner; H Masur
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

8.  Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.).

Authors:  M S Bartlett; J A Fishman; M M Durkin; S F Queener; J W Smith
Journal:  Exp Parasitol       Date:  1990-01       Impact factor: 2.011

9.  Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines.

Authors:  O W Lever; L N Bell; H M McGuire; R Ferone
Journal:  J Med Chem       Date:  1985-12       Impact factor: 7.446

Review 10.  Computer-assisted structure-activity correlations.

Authors:  M Nasr; K D Paull; V L Narayanan
Journal:  Adv Pharmacol Chemother       Date:  1984
View more
  10 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductase.

Authors:  A'Lissa B Gerum; Jonathan E Ulmer; David P Jacobus; Norman P Jensen; David R Sherman; Carol Hopkins Sibley
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

3.  Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance.

Authors:  D L Williams; L Spring; E Harris; P Roche; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 4.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

5.  Great efficacy of sulfachloropyrazine-sodium against acute murine toxoplasmosis.

Authors:  Yan-Bo Zeng; Shun-Hai Zhu; Hui Dong; Hong-Yu Han; Lian-Lian Jiang; Quan Wang; Jun Cheng; Qi-Ping Zhao; Wei-Jiao Ma; Bing Huang
Journal:  Asian Pac J Trop Biomed       Date:  2012-01

Review 6.  Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions.

Authors:  Aben Ovung; Jhimli Bhattacharyya
Journal:  Biophys Rev       Date:  2021-03-29

7.  Synthesis, antimicrobial and antioxidant activity of some oxindoles.

Authors:  S S Rindhe; B K Karale; R C Gupta; M A Rode
Journal:  Indian J Pharm Sci       Date:  2011-05       Impact factor: 0.975

8.  Synthesis and biological activities of some benzimidazolone derivatives.

Authors:  B K Karale; S S Rindhe; M A Rode
Journal:  Indian J Pharm Sci       Date:  2015 Mar-Apr       Impact factor: 0.975

9.  Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents.

Authors:  Martin Krátký; Jiřina Stolaříková; Jarmila Vinšová
Journal:  Molecules       Date:  2017-03-28       Impact factor: 4.411

10.  The Ultrastructural Effects of Sulfachloropyrazine on Toxoplasma gondii Tachyzoites.

Authors:  Yb Zeng; H Dong; Hy Han; Ll Jiang; Qp Zhao; Sh Zhu; Wj Ma; J Cheng; B Huang
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.